Lantheus CEO to Present at Two March 2026 Investor Conferences
Event summary
- Lantheus CEO Mary Anne Heino to present at TD Cowen Health Care Conference on March 3, 2026.
- Heino will also present at Leerink Global Healthcare Conference on March 10, 2026.
- Webcasts of presentations will be available on Lantheus' website for at least 30 days post-event.
- Lantheus is a radiopharmaceutical-focused company with operations in six countries.
The big picture
Lantheus' participation in two major investor conferences underscores its focus on engaging with the investment community amid growing interest in radiopharmaceutical solutions. The presentations come at a time when the healthcare sector is experiencing significant innovation and consolidation, with radiopharmaceuticals emerging as a key growth area. Lantheus' ability to articulate its value proposition clearly will be crucial in maintaining investor confidence and attracting new capital.
What we're watching
- Market Positioning
- How Lantheus will position its radiopharmaceutical portfolio in a competitive healthcare landscape.
- Investor Sentiment
- Whether the presentations will shift investor perception of Lantheus' growth prospects.
- Strategic Messaging
- The clarity and consistency of Lantheus' strategic messaging across both conferences.
Related topics